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Abstract
Background: Patient portal use could help improve the care and health outcomes of patients with diabetes owing to functionalities,
such as appointment booking, electronic messaging (e-messaging), and repeat prescription ordering, which enable patient-centered
care and improve patient self-management of the disease.
Objective: This review aimed to summarize the evidence regarding patient portal use (portals that are connected to electronic
health care records) or patient portal functionality use (eg, appointment booking and e-messaging) and their reported associations
with health and health care quality outcomes among adult patients with diabetes.
Methods: We searched the MEDLINE, Embase, and Scopus databases and reported the review methodology using the Preferred
Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Three independent reviewers screened titles
and abstracts, and two reviewers assessed the full texts of relevant studies and performed data extraction and quality assessments
of the included studies. We used the Cochrane Collaboration Risk of Bias Tool and the National Heart, Lung and Blood Institute
(NHLBI) Study Quality Assessment Tool to assess the risk of bias of the included studies. Data were summarized through narrative
synthesis.
Results: Twelve studies were included in this review. Five studies reported overall patient portal use and its association with
diabetes health and health care quality outcomes. Six studies reported e-messaging or email use–associated outcomes, and two
studies reported prescription refill–associated outcomes. The reported health outcomes included the associations of patient portal
use with blood pressure, low-density lipoprotein cholesterol, and BMI. Few studies reported health care utilization outcomes
such as office visits, emergency department visits, and hospitalizations. A limited number of studies reported overall quality of
care for patients with diabetes who used patient portals.
Conclusions: The included studies mostly reported improved glycemic control outcomes for patients with diabetes who used
patient portals. However, limitations of studying the effects of patient portals exist, which do not guarantee whether the outcomes
reported are completely the result of patient portal use or if confounding factors exist. Randomized controlled trials and
mixed-methods studies could help understand the mechanisms involved in health outcome improvements and patient portal use
among patients with diabetes.
Trial Registration: International Prospective Register of Systematic Reviews (PROSPERO) CRD42019141131;
https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42019141131.
International Registered Report Identifier (IRRID): RR2-10.2196/14975
(J Med Internet Res 2020;22(9):e18976) doi: 10.2196/18976
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Introduction
Background
Patient portals are online tools connected to health care systems’
electronic health records (EHRs). The portals may improve
patient health outcomes by improving communication with
health care providers, enabling self-management of the
disease, increasing patients’ involvement in care, empowering
patients, and improving their knowledge about the disease [1-6].
By offering access to information, such as visit summaries and
health records, portals can help patients review information and
remember doctors’ instructions [7,8]. Asynchronous
communication with health care providers through electronic
messages (e-messages) or emails (a potential functionality of
patient portals) can increase patients’ interaction with the health
care system and enable continuity of care [3,5,9,10]. Services,
such as repeat prescription refills through the portal, could also
improve efficiency and accelerate medication dispensing [3].
Rationale
The World Health Organization recommends a patient-centered
approach when it comes to diabetes care and the use of
technologies to engage patients [11]. The chronic care model,
an evidence-based approach to manage chronic diseases,
recommends “self-management support” to provide the best
care for patients with chronic diseases [12]. Synthesizing and
weighting the evidence about patient portals’ effectiveness in
improving diabetes health outcomes and quality of care could
help inform health care professionals and policymakers about
the potential benefits of patient portals.
There are several systematic reviews about patient portals used
by patients with diabetes. However, published reviews are either
outdated owing to new studies about patient portals being
published in the last 2 to 3 years [13-16] or do not report patient
outcomes [13]. Previous reviews that looked at diabetes health
outcomes associated with portal use had a broader definition of
portals and included portals that are co-delivered with other
interventions, such as a diabetes management system, home
visits [14], and coaching programs [16]. Another review only
reported on the user characteristics of patients with diabetes, as
well as facilitators and barriers of portal use [13], but did not
report on the health outcomes associated with portal use. We
hence aimed to close this gap by conducting a systematic review
to summarize and evaluate the study findings that reported
health and health care quality outcomes associated with the use
of patient portals among adult patients with diabetes.
Objective
We aimed to summarize the evidence regarding the use of
patient portals (portals that are connected to EHRs) and its
reported association with health and health care quality
outcomes among adult patients with diabetes. The review
research questions were as follows: (1) What kind of health
outcomes do patient portals contribute to in adult patients (18
years or older) with diabetes? (2) What kind of health care
quality outcomes, including health care utilization outcomes,
do patient portals contribute to in adult patients (18 years or
older) with diabetes?
Methods
Guidelines and Study Registration
This review was conducted following the Preferred Reporting
Items for Systematic Reviews and Meta-Analyses (PRISMA)
guidelines [17] (Multimedia Appendix 1). The protocol of the
review was registered in the International Prospective Register
of Systematic Reviews (PROSPERO) (registration number:
CRD42019141131) and was published in JMIR Research
Protocols (RR1-10.2196/14975) [18]. 
Eligibility Criteria
The population included adult patients with diabetes aged 18
years or older. The initial intent in the review protocol [18] was
to include all adult patient portal users, without focusing on
patients with a specific disease. However, owing to the large
number of studies reporting patient portal–related health
outcomes and the diversity of the patient populations studied,
we decided to focus on patients with diabetes only. The
intervention only included tethered patient portals that are
connected to a health care system’s EHR. We excluded studies
with additional interventions besides the patient portal, such as
a wearable device and a portal with a mood monitoring tool [19],
as we were unable to determine the outcomes associated with
portal use only. Studies with comparators and no comparators
were included. Outcomes of interest were health or health care
quality outcomes. Qualitative and conference papers were
excluded. Mixed-methods studies were only included if the
quantitative results were of the outcomes of interest of the study.
Finally, we excluded usability-only studies.
Information Sources
The MEDLINE, Embase, and Scopus databases were searched
for relevant articles. The complete search strategy for each
database has been provided in Multimedia Appendix 2. The
search was performed up to September 2019, but there was no
restriction on the start date of the search. 
Study Selection and Data Extraction
Three reviewers independently performed title and abstract
screening. Two reviewers (AA and AQ) independently
assessed all full texts for eligibility, while a third reviewer (PEA)
performed 25% (5 out of 20 articles) of the full-text reading.
Data extraction was also performed independently by the two
reviewers (AA and AQ). The extracted data included study
design, population characteristics, patient portal characteristics,
and study outcomes, and extraction was performed using the
Cochrane primary screening and data extraction tool
(Covidence) [20]. Any conflicts between the two reviewers
were resolved through discussions with the third reviewer
(PEA). 
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Risk of Bias
Studies were assessed for risk of bias using the Cochrane
Collaboration Risk of Bias Tool [21] for randomized controlled
trials (RCTs) and the National Heart, Lung and Blood Institute
(NHLBI) Study Quality Assessment Tool for observational
cohort and cross-sectional studies [22]. The NHLBI tool helps
identify the “internal validity of studies” by guiding the users
to identify methodological limitations [22]. Although studies
are rated as good, fair, or poor, the tool does not assign numeric
values or definite judgements of the quality of the studies. Thus,
it is up to the authors’ judgement to decide the severity of the
risk of bias in studies using the guidance questions. In this
review, we considered “good” as having a low risk of bias,
“fair” as having a moderate risk of bias, and “poor” as having
a high risk of bias. The risk of bias outcomes were considered
when interpreting study findings in the discussion section.
Data Synthesis
We were unable to carry out a meta-analysis owing to the
variation in outcomes and methodologies used in the included
studies. Therefore, we conducted a narrative synthesis of the
results from the included studies based on the study designs and
outcomes reported, paying attention to the relationship between
the studies. We examined the relationship between the studies
based on the patient portal functionalities. We decided to only
report the outcomes of interest in relation to the patient portal
functionality use because we found that there were similar
patterns in the outcomes reported based on the functionalities.
Although we collected information about the health care setting
of each of the included studies, we did not find sufficient
information to judge if the health care setting had a relevant
influence on the outcomes. Thus, we did not compare study
findings based on the health care setting. The narrative synthesis
followed the methodologies proposed by the Cochrane
Consumers and Communication Review Group data synthesis
and analysis document [23] and the methodologies proposed
as part of the UK Economic and Social Research Council
Methods Program [24].
Results
Study Selection
A total of 1120 records were initially identified from the
database searches (Figure 1). Among these, 830 studies were
excluded after title and abstract screening (conference papers
and irrelevant studies were excluded at this stage). Twenty full
texts were assessed for eligibility, of which eight were excluded
(Multimedia Appendix 3). Eventually, 12 studies were included
in the final review, and a narrative synthesis was
performed (Figure 1).
Figure 1. Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) flow diagram of the search and study selection process.
Characteristics of the Included Studies
A summary table of the characteristics of the included studies
is provided in Multimedia Appendix 4. Most of the studies were
from the United States (n=11), with only one study from Canada
[25]. Studies were performed in mixed settings including
primary, secondary, and tertiary care (outpatient setting), and
about half of the studies only included patients with type 2
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diabetes. The primary care setting included patient portals
offered by patients’primary care providers. The secondary care
setting included patient portals provided in a hospital setting.
The tertiary care setting included specialized outpatient care
(eg, diabetologists). Integrated health care systems included
primary care services provided in a hospital setting. None of
the studies specified whether the patient portal was used in an
in-patient setting. The retrospective cohort study design was
the design of choice in most cases, and there was one RCT [26]
and one cross-sectional study [27].
Table 1 lists the different patient portal functionalities used in
the included studies. The functionalities varied between studies
but mostly included viewing laboratory results (n=9), scheduling
appointments (n=6), refilling medications (n=7), and sending
messages or emails to health care providers (n=12) [25-36].
Other functionalities of the portals included requesting medical
advice, updating demographic information by patients [28],
entering flowsheet data, and offering a patient journal [25]. The
intervention portal in the RCT [26] allowed patients to edit their
medication lists, collected patient data on adverse effects of
medication and response to therapy, and allowed patients to
raise their health concerns through the portal. The control arm
(patient portal) of the RCT included similar functionalities to
the intervention portal and allowed patients to enter family
medical history and review their patient records concerning
nondiabetes-related health concerns such as cancer screening
[26].
Table 1. Patient portal functionalities in the included studies.
Patient portal functionalitiesStudy
OtherPatient educa-
tion
Secure mes-
sage/email
Repeat medica-
tion refill
Appointment book-
ing
Visit
notes
Lab results
Randomized controlled trials
YesNoYesYesYesNobYesaGrant et al, 2008 [26]
Retrospective cohort studies
YesYesYesYesYesYesYesChung et al, 2017 [28]
YesYesYesNoNoNoYesDevkota et al, 2016 [29]
YesYesYesNoNoNoYesLau et al, 2014 [25]
NoNoYesYesYesYesYesLyles et al, 2016 [30]
YesNoYesYesNoNoYesMcClellan et al, 2016 [31]
YesNoYesNoNoNoNoPetullo et al, 2016 [32]
YesNoYesYesYesNoNoPrice-Haywood et al, 2017
[33]
NoNoYesYesYesYesYesReed et al, 2019 [34]
YesNoYesYesNoNoNoShimada et al, 2016 [35]
NoYesYesNoNoNoYesTenforde et al, 2012 [36]
Cross-sectional studies
YesNoYesNoYesNoYesWade-Vuturo et al, 2013 [27]
aYes indicates availability of the functionality.
bNo indicates nonavailability or no mention of the functionality in the study.
Risk of Bias
The RCT included in this review [26] had a slightly high risk
of bias (Multimedia Appendix 5) stemming from not being able
to blind study participants or outcome assessors to the exposure
status of participants. The RCT also had a high risk of bias
owing to not reporting some of the study outcomes despite
mentioning the outcomes in the methods section [26].
We rated most of the observational studies as having a low or
moderate risk of bias (Multimedia Appendix 6). The studies
that we rated as having a low or moderate risk of bias generally
measured exposure before the outcomes [29,30,32-36], measured
different levels of exposure (eg, compared portal functionality
use by the number of days or number of times the functionality
was used instead of having only one category for usage)
[29-32,35,36], and controlled for key confounding variables
[29-31,34-36]. Few studies that looked at the frequency or
volume of e-messages, emails, or prescription refill use found
that patients who used the functionality the most had better
outcomes than patients who did not use the functionality or who
used it less frequently. For example, one study reported that
only patients who both read and wrote emails had much better
glycemic control at follow up (odds ratio [OR] 1.43, 95% CI
1.11-1.83), which was not true for patients only reading emails
or only using the patient portal [29]. Similarly, another study
found that the odds of glycemic control was the highest among
patients using the e-messaging functionality for 3 years or more
(OR 1.28, 95% CI 1.13-1.44) compared with portal-only users
(using the patient portal without the e-messaging functionality)
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[35]. One study found that patients sending four or more
messages per year were more likely to meet the glycemic control
threshold compared with those sending one message only (OR
1.55, 95% CI 1.43-1.69) [28].
Health Outcomes
Table 2 summarizes the different outcomes reported to be
associated with patient portal use, e-messaging or emailing, and
medication refill through the portal. Overall, patient portal use
was reported to be associated with glycemic control, reduced
glycated hemoglobin A1c (HbA1c%) at follow up, reduced blood
pressure, increased office visits, reduced hospitalizations,
medication adherence, and medication adjustment. One study
did not find a significant improvement in glycemic control as
a result of using a patient portal (P=.62); however, the study
offered both the control and experimental groups access to a
patient portal [26]. E-message or email use was reported to be
associated with glycemic control, reduced HbA1c% at follow
up, reduced low-density lipoprotein cholesterol, and increased
office visits. Only one study examined the difference in BMI
among portal users and nonusers and found no relevant
difference [36]. Refilling medications through the patient portal
was reported to be associated with glycemic control, blood
pressure control, and medication adherence [35]. Only one study
reported an association between refilling medications
exclusively through the patient portal and improved statin
adherence [30]. Although not listed in Table 2, one study found
no correlation regarding reviewing laboratory results; viewing
medical records; accessing billing information, the telephone
directory, maps/directions, and insurance information; finding
a doctor; and paying medical bills through the portal [27].
Table 2. Patient portal or patient portal functionality use and the reported associations with diabetes health and health care outcomes in the included
studies.
Prescription refill use (n=2)Electronic messaging or email use
(n=6)
Overall patient portal use (n=5)Outcome
Positive association (n=1) [35]Positive association (n=3) [28,29,35],
weak correlation (n=1) [27], no asso-
ciation (n=1) [31]
Positive association (n=1) [25], no
association (n=1) [26]
Glycemic control
—
aInverse association (n=3) [29,31,32]Inverse association (n=3)
[25,33,36]
Hemoglobin A1c (HbA1c%) at fol-
low up
Inverse association (n=1) [35]Inverse association (n=1) [35], no as-
sociation (n=1) [31]
No association (n=2) [25,36]Low-density lipoprotein cholesterol
Inverse association (n=1) [35]No association (n=2) [31,35]Inverse association (n=1) [36], no
association (n=1) [25]
Blood pressure
——No association (n=1) [36]BMI
—Positive association (n=1) [28]Positive association (n=1) [34]Office visits
—No association (n=1) [32]Inverse association (n=1) [34]Emergency visits
—No association (n=1) [32]Inverse association (n=1) [34]Hospitalization
Positive association (n=1) [30]——Medication adherence
——Positive association (n=1) [26]Medication adjustment
aThere were no studies reporting an association between functionality and outcome.
Diabetes Care Quality Outcomes
Three studies reported that patient portal or e-message users
were more likely to meet most of the diabetes care standards,
such as the Diabetes Healthcare Effectiveness Data and
Information Set (HEDIS) quality measures [28,31], or the
diabetes standards by the Better Health Partnership: Diabetes
Standards [36].
Discussion
Review of the Findings
Our review found a limited number of studies examining the
association between patient portal use and diabetes health and
health care quality outcomes. Nevertheless, among the studies
included, patient portal use or patient portal functionality use
was reported to be associated with improvements in health
outcomes, such as glycemic control. Secure messaging or
emailing, or repeat prescription ordering through the patient
portal was reported to be associated with improved glycemic
control, and outcomes appeared to improve with increased use.
It was also reported that patient portal use may be associated
with improved low-density lipoprotein cholesterol outcomes or
blood pressure control. Patient portal use or patient portal
functionality use might affect health care utilization and may
be associated with increased office visits and decreased
emergency department visits. Finally, some of the included
studies suggested that patient portal use might be associated
with improved quality of care for patients with diabetes.
The majority of studies we reviewed were determined to have
low to moderate risk of bias. However, some factors may not
be measured through standard risk of bias tools, which might
have affected the results reported by the studies. For instance,
it is challenging to separate outcomes that result exclusively
from portal use owing to the possibility of the presence of other
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factors that might confound the association. It is also challenging
to conclude which functionality of the patient portal contributes
the most to improving health outcomes, as some studies only
report overall portal use. It was previously reported that secure
messaging improves health outcomes for patients with diabetes
[14]. Increased contact between patients with diabetes and health
care professionals was one of the functionalities most associated
with reduced HbA1c in diabetes disease-management programs
as reported in a meta-analysis of studies [37]. Our review also
included studies that suggest glycemic control is improved in
patients who use secure messaging owing to improved
communication and increased access to care [29], resulting in
“better diabetes management” [28].
Outcomes related to the quality of care and health care
utilization were mixed. While some studies found reductions
in emergency visits, others did not. A previous study in a diverse
patient population found that there was no association between
patient portal use, hospital admission, and 30-day readmission,
suggesting that patient portals could be more effective in
managing chronic care than acute care [38]. Alternatively, one
of the included studies in this review suggested that actions
related to portal use, such as checking a test result, can increase
office visits, while actions, such as repeat prescription ordering
during the after-hours period, might reduce hospitalizations
[34]. A recent survey study of a patient portal with access to
health care records, test results, e-messaging, and appointment
booking reported that patients believed portal use helped them
“avoid a clinic visit” [39]. Few studies in the literature also
examined the association between patient portal use and missing
medical appointments [39,40], which was not examined in any
of the studies included in this review. The health care utilization
outcomes associated with patient portal use may need further
investigation as the number of studies examining these
associations is limited.
Knowledge Gap
The outcomes of this review indicate that there remain persistent
gaps in the literature about patient portals used by patients with
diabetes. First, there is some evidence that increased frequency
of patient portal or patient portal functionality use could be
associated with increased benefits, suggesting a dose-response
relationship. Patient portal adoption does not indicate continuous
use [40]. Since differences in the frequency of use may lead to
inconsistencies in benefits acquired from the patient portal,
studies need to account for the frequency of patient portal use
as much as possible. Additionally, there is a need for
mixed-methods studies to evaluate the mechanisms through
which portal use might impact the outcomes reported. Further
examination of health care utilization outcomes could help
understand if patient portals can play a role in improving health
care utilization patterns among patients with diabetes.
Limitations
The results reported by the studies in this review could be biased
owing to factors that may not have been controlled. For example,
patient portal users can be generally more motivated to be
involved in their care and to improve their health outcomes [29].
A cross-sectional study reported that patients who preferred
using portals had higher “self-determination” to manage their
health conditions [41]. RCTs could help explore causal
relationships between portal use and outcomes in patients with
diabetes. Additionally, qualitative studies or mixed-methods
studies can help explain if portal use or patient portal
functionality use is responsible for improving health and quality
of care outcomes among patients with diabetes. Qualitative
studies could help explore patients’ motives and patterns in
self-management to further help understand the mechanisms
involved in improving health outcomes through patient portal
use. There continues to be a need for studies to report outcomes
based on functionality whenever possible [16].
Although this review tried to report portal functionality–related
outcomes along with overall portal-related outcomes, most
included studies did not sufficiently report outcomes by
functionality. Another limitation of this review is that all studies,
except one, were from the United States, which has a diverse
health care system involving private health care organizations,
nonprofit organizations, and government-owned organizations.
The way that the health care organization is organized may limit
the application of the findings of this review to other health care
settings and systems.
Another limitation of this review is the small number of studies
included. The limited number of studies reduced the
generalizability of the review findings. However, the review
only attempted to identify associations as reported by the
included studies, which warrants further appropriately designed
studies in order to assess causal associations.
Conclusion
Most of the included studies reported improved glycemic control
outcomes for patients with diabetes who used patient portals.
However, limitations of studying the effects of patient portals
exist, which do not guarantee whether the outcomes reported
are completely the result of patient portal use or if confounding
factors exist. RCTs and mixed-methods studies could help
understand the mechanisms involved in health outcome
improvements and patient portal use among patients with
diabetes. 
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